Strategic cooperation is vital to Shenogen, as we firmly believe the most effective way to develop first-in-class drugs is to source and integrate the best available global innovation with in-house core competitiveness.  

We have established in-depth cooperation with a number of partners in China and overseas.  Several cooperation projects have successfully entered clinical phases. We constantly explore new opportunities to work with external organizations to develop novel and better medicine for the treatment of cancer and autoimmune diseases for the patents in China and worldwide. We adhere to a professional, respectful, open and flexible approach to work with our partners to achieve win-win cooperation.

We look forward to work with you. For more information about cooperation, please contact